Indivior Pharmaceuticals, Inc. (E7P)
FSX
Real-time Data
06:00 AM
Day's Range
31.4052 wk Range
18.50Overview - E7P - Indivior Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
3.45B
P/E (Trailing)
‪12.92‬
PEG Ratio
‪0.02‬
Price / Sales (TTM)
‪2.78‬
Price / Book
‪-17.87‬
EV / EBITDA
‪6.85‬
Profitability
Gross Margin
‪85.42%‬
Profit Margin
‪26.74%‬
Operating Margin
‪46.93%‬
Return on Assets
‪26.39%‬
Return on Equity
‪-212.12%‬
Ownership
Shares Outstanding
118.00M
Float
115.80M
Held by Insiders
‪1.82%‬
Held by Institutions
‪99.11%‬
Price stats
Beta
‪1.11‬
50-Day Avg
‪32.06‬
200-Day Avg
‪30.28‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - E7P - Indivior Pharmaceuticals, Inc.
Peers - E7P - Indivior Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- E7PFSXIndivior Pharmaceuticals, Inc.3.70BMarket Cap+37.58%52-week change12.92P/E (Trailing)‪26.74%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - E7P - Indivior Pharmaceuticals, Inc.
About
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on medicines for opioid use disorder and related substance use disorders. The company develops, manufactures, and markets buprenorphine-based prescription treatments designed to support recovery and long-term disease management in clinical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
